Veru secures US patent for enobosarm with semaglutide through late 2044
VERU•Veru received a US patent covering enobosarm with semaglutide, with protection extending until late 2044.
1. Patent protection
Veru received a US patent covering enobosarm with semaglutide, with protection extending until late 2044.




